2014
DOI: 10.1186/1756-3305-7-s1-p3
|View full text |Cite
|
Sign up to set email alerts
|

Recurrent subcutaneous human Dirofilariasis due to Dirofilaria repens after surgical removal of the worm and anthelmintic treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…There are several reports about autochthonous occurrence in humans and not only in endemic areas, but also in countries including Poland, Austria, Slovakia, and Romania [3,[25][26][27]. At our Departments, we have diagnosed five dirofilariasis cases from 2010 to 2012.…”
Section: Discussionmentioning
confidence: 94%
“…There are several reports about autochthonous occurrence in humans and not only in endemic areas, but also in countries including Poland, Austria, Slovakia, and Romania [3,[25][26][27]. At our Departments, we have diagnosed five dirofilariasis cases from 2010 to 2012.…”
Section: Discussionmentioning
confidence: 94%
“…The number of human dirofilariasis cases in Europe has increased from 264 (between 1995 and 1999) to 1782 (between 2000 and 2013), with epidemiological models predicting the evolution of this zoonosis from "emergent" to "endemic" status (Genchi et al 2011 b). So far, only a few isolated cases of human dirofilariasis have been reported in Romania, all of them in the south (Manescu et al 2009;Popescu et al 2012) and west of the country (Lupse et al 2014). Diagnoses were based on morphologic exams of the parasites in most of the cases, as molecular tests for parasitic species identification in Romania are limited to a few veterinary research laboratories.…”
Section: Resultsmentioning
confidence: 99%
“…Although little information is available on the treatment of D. repens in animals, surgical removal of the nodule remains the treatment of choice in human medicine. Albendazole, diethylcarbamazine, and ivermectin are recommended to prevent their recurrence [21,22].…”
Section: Introductionmentioning
confidence: 99%